SuperHealthy Rx publishes seven separate per-compound prices, including a microdosing lane for each weight-loss molecule, and says in its own words that every dose costs the same. Two of those prices render with no currency symbol at all, and two of the seven are priced behind a coming-soon button rather than an order button.
What SuperHealthy Rx charges
Semaglutide: $199/mo — starting at, per month; this card renders the number with no currency symbol
Tirzepatide: $249/mo — starting at, per month; this card renders the number with no currency symbol
Semaglutide: $199/mo — starting at, for a one-month supply; the product carries a coming-soon button rather than an order button
Tirzepatide: $199/mo — starting at, for a one-month supply; the product carries a coming-soon button rather than an order button
Sermorelin: $195/mo — starting at, for a one-month supply
NAD+: $299/mo — starting at, for a one-month supply
NAD+: $149/mo — starting at, for a one-month supply
SuperHealthy Rx is not a paid partner; this link may earn a commission if that changes. Full disclosure.
By Nora Castellan, Standards EditorUpdated September 2026
Two prices render as bare numbers
On its GLP-1 page the visible text for each weight-loss product is the word "Starting at" followed by a bare number and a per-month suffix.
The markup emits the figure with no currency symbol and the stylesheet adds none; its microdosing, NAD+ and sermorelin templates all print the symbol correctly, so this is a defect on one template rather than a house style.
The figures are recorded here as the seller's prices, because the copy around them makes the unit unambiguous. The defect is recorded too.
Priced but not orderable
Its two microdosing products, one for each weight-loss molecule, each carry a published price as visible text.
Each also carries a "Coming Soon" button where an order button would be.
They are filed with that noted. A figure a reader can see is a published price, but nobody can buy at it yet.
Dose-flat pricing, stated plainly
Asked in its own FAQ whether higher doses cost more, it answers: "No. One of our biggest advantages is that all doses cost the same".
That is a useful thing to have in writing, because a titration on a per-dose seller can move the number several times over a course.
It also prices the injectable and the nasal forms of NAD+ separately rather than folding both into one figure.
What it will not tell you
It names no pharmacy and says why: "To learn which pharmacy will handle your prescription, please contact us."
Its state sentence names four states, but for a different reason — which physicians are assigned where — not for availability, and no availability list is published anywhere. No states are recorded here.
Its compounded-category language is thin. Beyond confirming its tirzepatide is typically formulated with a B vitamin, it says only that it does "not recommend or endorse any specific prescription drug or product or health care provider or pharmacy that may be mentioned on the Site". It does publish medical-board complaint notices for three states.
Who it's for
Readers comparing microdosing against full-dose lanes at one seller.
Buyers who want the injectable and nasal NAD+ forms priced separately.
Shoppers titrating upward who want the price held flat across doses.
Anyone who wants a seller to say in writing why the dose does not change the bill.
Who should look elsewhere
Readers who want the dispensing pharmacy named before ordering.
Buyers who need to know whether the service reaches their state.
Anyone who wants to order a microdosing product today rather than wait.
Shoppers who want a clear statement about the compounded category.
Strengths
Prices seven separate products, including a microdosing lane for each weight-loss molecule
Says in its own words that every dose costs the same and explains why
Prices the injectable and nasal NAD+ forms separately
Publishes medical-board complaint notices for three states
Trade-offs
Two of its prices render with no currency symbol at all
Its two microdosing products are priced but carry a coming-soon button rather than an order button
Names no pharmacy and directs readers to contact it to find out which one will fill
Publishes no availability list; the four states it names are about physician assignment
How we verified this
Read each price as visible text on its own product page, and confirmed that two of the seven render with no currency symbol while the other templates print one.
Confirmed both microdosing products publish a figure as visible text and carry a coming-soon button in place of an order button, then filed them with that noted.
Read the four-state sentence in its own context, found it describes physician assignment rather than availability, and recorded no states from it.
Requested a deliberately meaningless address on this host in the same session and confirmed it returns a not-found response.
Screened the brand in two spellings and its legal entity against the live federal warning-letter table through a matcher that normalises both the query and the filed company name before comparing, and found no letters.
A provider to compare SuperHealthy Rx against
Trellis Vitality
Trellis Vitality frames its program around body-composition tracking rather than scale weight, pairing NAD+, glutathione and tesamorelin with at-home biomarker panels and a 90-day re-test, and names its dispensing pharmacy, VialsRX in Houston, by address.
The GLP-1 template emits the number without one and the stylesheet adds none, so the visible text is a bare figure with a per-month suffix. Its other product templates print the symbol normally.
Can I order the microdosing products?
Not yet. Both publish a price as visible text but carry a coming-soon button rather than an order button.
Does a higher dose cost more?
No. The seller answers this directly in its own FAQ and says all doses cost the same.
Which pharmacy fills the prescription?
It does not say. Its own copy tells readers to contact the company to find out which pharmacy will handle the prescription.
SuperHealthy Rx is not a paid partner; this link may earn a commission if that changes. Full disclosure.